LIGAND PHARMACEUTICALS INCORPORATED (LGND) Debt Components
- 2026-06-30: Long-term DebtUSD $1.13B; Long-term Debt, GrossUSD $1.16B; Long-term Debt, Fair ValueUSD $1.41B; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $33.41M.
- 2019-09-30: Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD (m).
- 2019-06-30: Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD (m).
- 2018-12-31: Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD (m).
LIGAND PHARMACEUTICALS INCORPORATED Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Long-term Debt, Gross USD | Long-term Debt, Fair Value USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Notes Payable, Current USD | Notes Payable USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Five USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Line of Credit Facility, Periodic Payment USD | Debt Instrument, Convertible, Conversion Ratio pure | Debt Instrument, Convertible, If-converted Value in Excess of Principal USD | Debt Instrument, Convertible, Threshold Consecutive Trading Days D | Debt Instrument, Convertible, Carrying Amount of Equity Component USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.13B | $1.16B | $1.41B | $33.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $0.00 | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $0.00 | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $31.57M | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $31.57M | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $16.08M |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $18.86M |
| 2017-12-31 | (m) | (m) | (m) | (m) | $224.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 50.00 | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $21.60M |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $24.29M |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $26.95M |
| 2016-12-31 | (m) | (m) | (m) | (m) | $212.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $29.56M |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $32.14M |
| 2015-12-31 | (m) | (m) | (m) | (m) | $201.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $39.63M |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $245.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | $202.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | $200.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | $348.00K | $198.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | $334.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | $196.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $245.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | $337.00K | $193.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 1332.51% | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | $2.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | $5.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $9.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | $9.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | $12.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $400.00K | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | $13.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $400.00K | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | $13.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $14.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $27.50M | (m) | (m) | (m) | (m) | (m) | $14.84M | $12.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | $10.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | $5.81M | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | $1.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |